Cargando…
Possible life-threatening adverse reaction to monovalent H1N1 vaccine
Autor principal: | Bhurayanontachai, Rungsun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911725/ https://www.ncbi.nlm.nih.gov/pubmed/20553634 http://dx.doi.org/10.1186/cc9022 |
Ejemplares similares
-
Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines
por: Woo, Jennifer C., et al.
Publicado: (2009) -
Maximal Glycemic Difference, the Possible Strongest Glycemic Variability Parameter to Predict Mortality in ICU Patients
por: Issarawattana, Thanaphruet, et al.
Publicado: (2020) -
Adverse Events Following Pandemic A (H1N1) 2009 Monovalent Vaccines in Pregnant Women — Taiwan, November 2009–August 2010
por: Huang, Wan-Ting, et al.
Publicado: (2011) -
Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women
por: Weinberg, Adriana, et al.
Publicado: (2015) -
Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients
por: Pitt, Tracy, et al.
Publicado: (2011)